Retraction notice to “Hepatocyte growth factor-induced expression of ornithine decarboxylase, c-met,and c-mycIs differently affected by protein kinase inhibitors in human hepatoma cells HepG2” [Exp. Cell Res. 242 (1998) 401–409] (Experimental Cell Research (2013) 319(12) (1865–1874), (S0014482713001936), (10.1016/j.yexcr.2013.04.022));Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism

Experimental Cell Research

Volumn 319, Issue 12, 2013, Pages 1865-1874

  Matteucci, Emanuela ^a   Maroni, Paola ^b   Bendinelli, Paola ^a   Locatelli, Alessia ^a,c   Desiderio, Maria Alfonsina ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Bone metastasis; DNA methylation; Endothelin axis; HDACs

Indexed keywords

AZACITIDINE; DACTINOMYCIN; DNA METHYLTRANSFERASE; ENDOTHELIN 1; HISTONE DEACETYLASE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRICHOSTATIN A;

ARTICLE; BONE; BONE METASTASIS; BONE TROPISM; BREAST CARCINOMA CELL; CARCINOMA CELL; CELL INVASION; CONTROLLED STUDY; DEMETHYLATION; EPIGENETICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEADY STATE; TROPISM; WILD TYPE;

EID: 84879604260     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2020.112171     Document Type: Erratum

References (44)

1. Matteucci E., Maroni P., Luzzati A., Perrucchini G., Bendinelli P., Desiderio M.A. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and Wwox nuclear effectors. Eur. J. Cancer 2013, 49:231-244.
2. Morange M. The relations between genetics and epigenetics: a historical point of view. Ann. N.Y. Acad. Sci. 2002, 981:50-60.
3. Kedzierski R., Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 2001, 41:851-876.
4. Baganto A., Spinella F., Rosanò L. Emerging role of the endothelin axis in ovarian tumor progression. Endocr. Relat. Cancer 2005, 12:761-772.
5. Rosanò L., Spinella F., Salani D., Di Castro V., Venuti A., Nicotra M.R., Natali P.G., Bagnato A. Therapeutic targeting of the endothelin A receptor in human ovarian carcinoma. Cancer Res. 2003, 63:2447-2453.
6. Rosanò L., Di Castro V., Spinella F., Nicotra M.R., Natali P.G., Bagnato A. ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo. Mol. Cancer Ther. 2007, 6:2003-2011.
7. Li Y., Liao Q., Li K., Zhong D., Weng X., Mi M. Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model. Mol. Med. Rep. 2012, 5:1391-1395.
8. Berry P.A., Zhang Y.F., Carter N.D., Jeffery S., Burchill S.A. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells. Med. Pediatr. Oncol. 2001, 36:142-146.
9. Mauschitz R., Cervar M., Hahn T., Pürstner P., Desoye G. Self-regulation of the endothelin receptor system in choriocarcinoma cells. Biochim. Biophys. Acta 2000, 1502:224-234.
10. Berger Y., Bernasconi C.C., Juillerat-Jeanneret L. Targeting the endothelin axis in human melanoma: combination on endothelin receptor antagonism and alkylating agent. Exp. Biol. Med. 2006, 231:1111-1119.
11. Said N., Theodorescu D. Permissive role of endothelin receptors in tumor metastasis. Life Sci. 2012, 91:522-527.
12. Dumont N., Wilson M.B., Crawfold Y.G., Reynolds P.A., Sigaroudinia M., Tlsty T.D. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancer. Proc. Natl. Acad. Sci. USA 2008, 105:14867-14872.
13. Carey N., La Thangue N.B. Histone deacetylase inhibitors: gathering pace. Curr. Opin. Pharmacol. 2006, 6:369-375.
14. Feng W., Dong Z., He B., Wang K. Analysis method of epigenetic DNA methylation to dynamically investigate the functional activity of transcription factors in gene expression. BMC Genomics 2012, 13:532-538.
15. Bendinelli P., Maroni P., Matteucci E., Desiderio M.A. Comparative role of acetylation along c-Src/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes. Biochim. Biophys. Acta 2011, 1813:1767-1776.
16. Marjanovic N.D., Weinberg R.A., Chaffer C.L. Cell plasticity and heterogeneity in cancer. Clin. Chem. 2013, 59:168-179.
17. Park S.Y., Jun J.A., Jeong K.J., Heo H.J., Sohn J.S., Lee H.Y., Park C.G., Kang J. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. Oncol. Rep. 2011, 25:1677-1681.
18. Zhang Z., Yamashita H., Toyama T., Sugiura H., Omoto Y., Ando Y., Mita K., Hamaguchi M., Hayashi S., Iwase H. HDAC6 expression is correlated with better survival in breast cancer. Clin. Cancer Res. 2004, 10:6962-6968.
19. Valenzuela-Fernández A., Cabrero J.R., Serrador J.M., Sánchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell. Biol. 2008, 18:291-297.
20. Ehrlich M., Lacey M. DNA hypomethylation and hemimethylation in cancer. Adv. Exp. Med. Biol. 2013, 754:31-56.
21. Reimunde F.M., Castañares C., Redondo-Horcajo M., Lamas S., Rodríguez-Pascual F. Endothelin-1 expression is strongly repressed by AU-rich elements in the 3'-untranslated region of the gene. Biochem. J. 2005, 387:763-772.
22. He F., Li J., Mu Y., Kuruba R., Ma Z., Wilson A., Alber S., Jiang Y., Stevens T., Watkins S., Pitt B., Xie W., Li S. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ. Res. 2006, 98:192-199.
23. Misquitta C.M., Iyer V.R., Werstiuk E.S., Grover A.K. The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol. Cell. Biochem. 2001, 224:53-67.
24. Maroni P., Matteucci E., Luzzati A., Perrucchini G., Bendinelli P., Desiderio M.A. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma. Breast Cancer Res. Treat. 2011, 129:433-450.
25. Ridolfi E., Matteucci E., Maroni P., Desiderio M.A. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. Br. J. Cancer 2008, 99:1623-1634.
26. Bendinelli P., Matteucci E., Maroni P., Desiderio M.A. NF-κB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. Mol. Cancer Res. 2009, 7:1328-1341.
27. Wang G., Guo X., Floros J. Differences in the translation efficiency and mRNA stability mediated by 5'-UTR splice variants of human SP-A1 and SP-A2 genes. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289:L497-L508.
28. Chang J., Varghese D.S., Gillam M.C., Peyton M., Modi B., Schiltz R.L., Girard L., Martinez E.D. Differential response of cancer cells to HADC inhibitors trichostatin A and depsipeptide. Br. J. Cancer 2012, 106:116-125.
29. De Amicis F., Giordano F., Vivacqua A., Pellegrino M., Panno M.L., Tramontano D., Fuqua S.A., Andò S. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J. 2011, 25:3695-3707.
30. Yamashita K., Discher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J. Biol. Chem. 2001, 276:12645-12653.
31. Takai D., Yagi Y., Wakazono K., Ohishi N., Morita Y., Sugimura T., Ushijima T. Silencing of HTR1B and reduced expression of EDN1 in human lung cancer, revealed by methylation-sensitive representational difference analysis. Oncogene 2001, 20:7505-7513.
32. Ishimoto S., Wada K., Tanaka N., Yamanishi T., Ishihama K., Aikawa T., Okura M., Nakajima A., Kogo M., Kamisaki Y. Role of endothelin receptor signalling in squamous cell carcinoma. Int. J. Oncol. 2012, 40:1011-1019.
33. Hamm C.A., Xie H., Costa F.F., Vanin E.F., Seftor E.A., Sredni S.T., Bischof J., Wang D., Bonaldo M.F., Hendrix M.J., Soares M.B. Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity. PLoS One 2009, 4:e8340.
34. Gu X., Sun J., Li S., Wu X., Li L. Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanism in gene transcription in Aβ production. Neurobiol. Aging 2013, 34:1069-1079.
35. Weber C.E., Kuo P.C. The tumor microenvironment. Surg. Oncol. 2012, 21:172-177.
36. Maroni P., Brini A.T., Arrigoni E., de Girolamo L., Niada S., Matteucci E., Bendinelli P., Desiderio M.A. Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic trascription factors. Biochem. Biophys. Res. Commun. 2012, 428:271-277.
37. Rodríguez-Pascual F., Redondo-Horcajo M., Magán-Marchal N., Lagares D., Martínez-Ruiz A., Kleinert H., Lamas S. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol. Cell. Biol. 2008, 28:7139-7155.
38. Khanna A., Okkeri J., Bilgen T., Tiirikka T., Vihinen M., Visakorpi T., Westermarck J. ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells. PLoS One 2011, 6:e17979.
39. Zhang Y., Yan L.X., Wu Q.N., Du Z.M., Chen J., Liao D.Z., Huang M.Y., Hou J.H., Wu Q.L., Zeng M.S., Huang W.L., Zeng Y.X., Shao J.Y. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res. 2011, 71:3552-3562.
40. Fry C.J., Farnham P.J. Context-dependent transcriptional regulation. J. Biol. Chem. 1999, 274:29583-29586.
41. Inoue A., Yanagisawa M., Takuwa Y., Mitsui Y., Kobayashi M., Masaki T. The human preproendothelin-1 gene. J. Biol. Chem. 1989, 264:14954-14959.
42. Zhang Y.F., Jeffery S., Burchill S.A., Berry P.A., Kaski J.C., Carter N.D. Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. Br. J. Cancer 1998, 78:1141-1146.
43. Pattani K.M., Zhang Z., Demokan S., Glazer C., Loyo M., Goodman S., Sidransky D., Bermudez F., Jean-Charles G., McCaffrey T., Padhya T., Phelan J., Spivakovsky S., Bowne H.Y., Goldberg J.D., Rolnitzky L., Robbins M., Kerr A.R., Sirois D., Califano J.A. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev. Res. 2010, 3:1093-1103.
44. Ropero S., Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol. Oncol. 2007, 1:19-25.